C-Bridge Capital - Unicorn Nest

C-Bridge Capital

Headquarters Location

United States, New York


C-Bridge Capital is the renowned VC, which was created in 2014. The fund is located in China, Asia. The primary office of this VC is located in Shanghai.

The fund usually invests in rounds together with 3-4 others. Besides C-Bridge Capital, start-ups are typically funded by Thomas, McNerney & Partners, Tasly Pharmaceutical, Qiming Venture Partners and 1 more VC. Other VCs who often invest in the same rounds are Tasly Pharmaceutical, Qianhai Fund of Funds, WTT Investment. In subsequent rounds, the fund is usually supported by Tasly Pharmaceutical, Xiamen Venture Capital, WTT Investment.

Also, a start-up has to be aged 4-5 years to expect investment from this fund. The fund has specific requirements for the number of founders in a start-up. Among their most successful investment fields, we have identified Medical, Product Research. Also, because of its portfolio diversification tendency, we can highlight 9 more industries for this fund. Among the most popular portfolio start-ups of the fund, are Ascletis, I-Mab Biopharma, CMAB BioPharm. The country of its establishment and the country of its most frequent investments coincides - China. However, start-ups from 1 other country can be found in the fund's portfolio.

C-Bridge Capital is involved in 12 percentage points less than the average amount of lead investments when compared with other funds. This fund was the most active in 2018. Additionally, in 2019 the fund was active. In terms of the fund's performance, this VC has 47 percentage points more exits when compared to other organizations. The fund usually participates in 2-6 investment rounds per year. The highest number of exits from this fund were in 2018. When C-Bridge Capital invests, the average start-up valuation is 100-500 millions dollars. Typical investments for this fund are deals in the range of 50 - 100 millions dollars.

The overall number of key employees in the fund's team is 11.

Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: cbridgecap.com; User name format in descending order of probability: first '.' last, first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

85.7% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

28.6% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

8.5 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.15 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]


Funds Investing in Following

Tasly Pharmaceutical, Xiamen Venture Capital, WTT Investment

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: